TendieTensor TendieTensor
You’re browsing as
Guest
Free Preview
Sign in/sign up to unlock all features.

News  ›  GlobeNewswire Inc.

Keros Therapeutics Announces Preliminary Results of Tender Offer

GlobeNewswire Inc. Logo GlobeNewswire Inc. By Keros Therapeutics, Inc.
Keros Therapeutics Announces Preliminary Results of Tender Offer

Keros Therapeutics completed a cash tender offer to repurchase up to 10,950,165 shares of its common stock at $17.75 per share, totaling approximately $194.4 million. More shares were tendered than the target, so shares will be accepted on a pro rata basis.

Insights
KROS   neutral

The company is executing a planned capital return program by repurchasing shares, which indicates financial stability and strategic financial management. The neutral sentiment reflects a routine corporate financial action without significant positive or negative implications.